http://www.unboundmedicine.com/medline/ebm/research/nonsteroidal_anti_inflammatory_agentsUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19925388/full_citation/Genetic_Polymorphism_of_the_Human_Cytochrome_P450_2C9_Gene_and_Its_Clinical_Significance_Wang B, Wang J, Huang SQ, et al. 
Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance. [JOURNAL ARTICLE]
Curr Drug Metab 2009 Sep; 10(7):781-834.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19916560/full_citation/R_flurbiprofen_reverses_multidrug_resistance_proliferation_and_metastasis_in_gastric_cancer_cells_by_p75NTR_induction_Jin H, Wang Z, Fan D 
R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75NTR induction. [JOURNAL ARTICLE]
Mol Pharm 2009 Nov 16.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19897667/full_citation/Aspirin_for_primary_prevention_of_vascular_disease_in_people_with_diabetes_Haynes R, Bowman L, Armitage J 
Aspirin for primary prevention of vascular disease in people with diabetes. [Comment, Editorial]
BMJ 2009.:b4596.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19897665/full_citation/Aspirin_for_primary_prevention_of_cardiovascular_events_in_people_with_diabetes:_meta_analysis_of_randomised_controlled_trials_De Berardis G, Sacco M, Strippoli GF, et al. 
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. [Journal Article, Meta-Analysis, Review]
BMJ 2009.:b4531.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19892717/full_citation/Role_of_TGF_{beta}s_in_normal_human_endometrium_and_endometriosis_Omwandho CO, Konrad L, Halis G, et al. 
Role of TGF-{beta}s in normal human endometrium and endometriosis. [JOURNAL ARTICLE]
Hum Reprod 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19892664/full_citation/Chemopreventive_efficacy_of_naproxen_and_nitric_oxide_naproxen_in_rodent_models_of_colon_urinary_bladder_and_mammary_cancers_Steele VE, Rao CV, Zhang Y, et al. 
Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers. [Journal Article, Research Support, N.I.H., Extramural]
Cancer Prev Res (Phila Pa) 2009 Nov; 2(11):951-6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19889203/full_citation/Synergistic_chondroprotective_effects_of_curcumin_and_resveratrol_in_human_articular_chondrocytes:_inhibition_of_interleukin_1beta_induced_nuclear_factor_kappaB_mediated_inflammation_and_apoptosis_Csaki C, Mobasheri A, Shakibaei M 
Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of interleukin-1beta-induced nuclear factor-kappaB-mediated inflammation and apoptosis. [JOURNAL ARTICLE]
Arthritis Res Ther 2009 Nov 4; 11(6):R165.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888506/full_citation/Infliximab_treatment_in_a_case_of_rheumatoid_scleromalacia_perforans_Herrera-Esparza R, Avalos-Díaz E 
Infliximab treatment in a case of rheumatoid scleromalacia perforans. [Journal Article]
Reumatismo 2009 Jul-Sep; 61(3):212-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887912/full_citation/Role_of_ATF4_in_regulation_of_autophagy_and_resistance_to_drugs_and_hypoxia_Rzymski T, Milani M, Singleton DC, et al. 
Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia. [JOURNAL ARTICLE]
Cell Cycle 2009 Dec 15; 8(23)
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884622/full_citation/Treatment_of_very_early_rheumatoid_arthritis_with_symptomatic_therapy_disease_modifying_antirheumatic_drugs_or_biologic_agents:_a_cost_effectiveness_analysis_Finckh A, Bansback N, Marra CA, et al. 
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. [Journal Article, Research Support, Non-U.S. Gov't]
Ann Intern Med 2009 Nov 3; 151(9):612-21.
Abstract | Full Citation | Publisher Full Text | Find Related Articles